Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
Vasoactive inhibitory peptide (VIP) and secretin were compared in regard to the stimulation of pancreatic bicarbonate secretion and the augmentation of pancreatic response to caerulein or a peptone meal in chronic gastric and pancreatic fistula dogs. Dose-response analysis showed that maximal bicarbonate response to VIP was about 17% of that to secretin. Both caerulein and endogenous cholecystokinin, released by a peptone meal, clearly potentiated pancreatic bicarbonate response to VIP in a manner similar to secretin. The interactions of these two peptides showed that VIP is a potent inhibitor of secretin-induced pancreatic secretion. From the dose-response curves to secretin alone and secretin plus VIP, Michaelis-Menten analysis showed typical competitive inhibition, which indicates that VIP and secretin share a common receptor site.
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004357:Drug Synergism; D005747:Gastric Fistula; D005768:Gastrointestinal Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D007263:Infusions, Parenteral; D007700:Kinetics; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism; D010185:Pancreatic Fistula; D010189:Pancreatic Juice / Q000378:metabolism; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D010461:Peptones / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology*
D001639:Bicarbonates; D004338:Drug Combinations; D005768:Gastrointestinal Hormones; D010455:Peptides; D010461:Peptones; D011506:Proteins; D012633:Secretin; D002108:Ceruletide; D002766:Cholecystokinin; D000681:Amylases